The Asia Pacific Hair Loss Treatment Products Market is supposed to grow at a compound annual growth rate (CAGR) of 4.8% during the forecast period of 2021 – 2026 owing to the factors such as increased stress and elderly population in different nations of this area.
Driving Factors:-
One of the major driving factors that helps the growth of the Asia Pacific Hair Loss Treatment Products Market is the growing pollution, change in diet leads to hair loss problems especially in some of the emerging economies such as India and China, which is also supposed to boost the local market in the coming years.
Increased aging population and rising stress among the young population which was followed by pollution concerns are other driving aspects of the Asia Pacific Hair Loss Treatments Products market.
Segmentation Analysis:-
The Asia Pacific Hair Loss Treatment Products Market is segmented and sub-segmented into the following categories:
Among these, the dermatology clinics accounted for the significant portion, which is estimated to overtaken by homecare settings in the coming years.
Regional Analysis:-
Asia Pacific region expected to record an increase in the market share of Hair Loss Treatments Products owing to the new product launches by major players especially on herbal and natural ingredients to promote the hair growth, increased hair loss due to changing lifestyles and exposure to the environment, growing pollution, change in diet leads to hair loss problems particularly in some of the emerging economies such as India and China in this area in the next few years.
Key market players:-
Some of the key players of Hair Loss Treatment Products Market are Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Merck & Co., Inc, Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.
Due to the Coronavirus, Asia Pacific Hair Loss Treatment Products Market is also facing difficulties and witnessed financial losses due to financial crisis they had faced. Since most number of cases were found in Asia Pacific region, the government authorities made strict lockdown regulations to eradicate the spread of COVID-19 which in turn made all the businesses to get huge losses due to shutdown of their businesses. As per the analysis, experts from the industry are predicting that the market will boost up and will be back to the normal stage since the vaccine has released recently in so many countries. The government have already lifted the lockdown in most of the countries and also gave permission for the manufacturing companies to start their businesses with strict rules and regulations.
Increasing concerns among the people regarding the hair loss across the area especially among the females is one of the major driving factors that helps the market to grow further during the outlook period of 2021 to 2026. As per the report, the market of hair loss treatments products is estimated to increase much further owing to increased aging population and rising stress among the young population which was followed by pollution concerns that in turn will be helpful to increase the revenue rate in the upcoming years.
1. Introduction
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.1.1 Drivers
4.1.2 Restaints
4.1.3 Opportunities
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.2 Products/Service
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Hair Loss Treatment Products Market, By Disease Type
6.1.1 Alopecia Areata
6.1.2 Cicatricial Alopecia
6.1.3 Traction Alopecia
6.1.4 Alopecia Totalis
6.1.5 Alopecia Universalis
6.1.6 Androgenetic Alopecia
6.1.7 Market Size Estimations & Forecasts (2019-2024)
6.1.8 Y-o-Y Growth Rate Analysis
6.1.9 Market Attractiveness Index
6.2 Hair Loss Treatment Products Market, By End-Use
6.2.1 Homecare Settings
6.2.2 Dermatology Clinics
6.2.3 Market Size Estimations & Forecasts (2019-2024)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 Hair Loss Treatment Products Market, By Sales Channel
6.3.1 Over the Counter (OTC)
6.3.2 Prescription
6.3.3 Market Size Estimations & Forecasts (2019-2024)
6.3.4 Y-o-Y Growth Rate Analysis
6.3.5 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2018 - 2024)
7.2.1 By Country
7.2.1.1 USA
7.2.1.2 Canada
7.2.2 By Disease Type
7.2.3 By End-Use
7.2.4 By Sales Channel
7.3 Europe
7.3.1 By Country
7.3.1.1 UK
7.3.1.2 France
7.3.1.3 Germany
7.3.1.4 Spain
7.3.1.5 Italy
7.3.1.6 Rest of Europe
7.3.2 By Disease Type
7.3.3 By End-Use
7.3.4 By Sales Channel
7.4 Asia Pacific
7.4.1 By Country
7.4.1.1 China
7.4.1.2 India
7.4.1.3 Japan
7.4.1.4 South Korea
7.4.1.5 South East Asia
7.4.1.6 Australia & NZ
7.4.1.7 Rest of Asia-Pacific
7.4.2 By Disease Type
7.4.3 By End-Use
7.4.4 By Sales Channel
7.5 Latin America
7.5.1 By Country
7.5.1.1 Brazil
7.5.1.2 Argentina
7.5.1.3 Mexico
7.5.1.4 Rest of Latin America
7.5.2 By Disease Type
7.5.3 By End-Use
7.5.4 By Sales Channel
7.6 Middle East and Africa
7.6.1 By Country
7.6.1.1 Middle East
7.6.1.2 Africa
7.6.2 By Disease Type
7.6.3 By End-Use
7.6.4 By Sales Channel
8. Key Player Analysis
8.1 Histogen Inc.,
8.1.1 Business Description
8.1.2 Products/Service
8.1.3 Financials
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Concert Pharmaceuticals Inc.
8.3 Dr. Reddy's Laboratories Ltd.
8.4 Alès Groupe
8.5 Merck & Co., Inc
8.6 Alpecin, Vitabiotics Ltd.
8.7 Sun Pharmaceutical Industries Ltd
8.8 GlaxoSmithKline
8.9 Johnson and Johnson
8.10 Cipla
8.11 Daiichi Sankyo, Inc.
8.12 Hcell Inc.
9. Market Outlook & Investment Opportunities
Appendix
List of Tables
List of Figures
